Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d68d1afa81c3863c287da54db756f6b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9136549e91ac59221f028789b57cfb0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da93b97355fb3b61fe4c7644f38a9bb6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f97ee93c370574421011a00031e54b5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c18688c711607d758d504426c959804 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
filingDate |
2010-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0989769d8c887dac88e3f34c6746d640 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73990876fd941c4248fe2cdc5d29b109 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_218749f8f9c3f46f8f5770d050e0f8d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_664a61fde558f0e6f36d081e2cef2e30 |
publicationDate |
2014-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8835164-B2 |
titleOfInvention |
Cell line stably expressing mutated oncoprotein E6 and method of screening anticancer compound of uterine cervical cancer using the same |
abstract |
Disclosed are a cell line that expresses protein of Seq. No. 1, and a method for screening an anticancer compound of uterine cervical cancer by using the same. The stable cell line that expresses oncoprotein E6 of a human papillomavirus type 16 variant strain is used to determine a difference in amounts of expression of tumor suppressor genes, such as p53, between E6 protein of the reference strain and E6 protein of a variant strain, thereby screening an anticancer compound of uterine cervical cancer, etc. Further, it is possible to develop an anticancer agent of uterine cervical cancer. |
priorityDate |
2009-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |